Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 13-2 (KRTAP13-2) is a structural protein belonging to the keratin-associated protein (KAP) family, notably involved in the formation and structural integrity of the hair and wool fiber shaft[3][5]. It is classified as a high-sulfur KAP, characterized by high cysteine content, which allows extensive disulfide bond formation with hair keratin intermediate filaments, resulting in increased rigidity and resilience of hair or wool[2][3]. The gene is expressed in the hair shaft, particularly in the cuticle and cortex, supporting structural roles in mammalian integument. Variation in KRTAP13-2, particularly in sheep, has been associated with differences in fiber diameter uniformity, suggesting its potential use as a genetic marker for selective breeding of wool quality traits[1]. There are currently no known therapeutic drugs, safety concerns, or major pathological roles associated with this protein in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 13-2 (KRTAP13-2).